Postdoc: Targeted Protein Degradation in Cancer Drug Discovery

RFCSR; Dundee; On-site; GBP 37,000 - 45,000; Full time

Job summary

The University of Dundee's CeTPD invites applications for a Postdoctoral Research Assistant to join the ACBI-glue team, focusing on developing molecular glue degraders for cancer targets.

You'll identify ubiquitin E3 ligases, validate interactions in cellular and in vitro systems, and apply high-throughput screening to discover small molecules that act as molecular glues, contributing to translational cancer therapeutics.

Qualifications

• PhD in cell biology, molecular/biomedical sciences, molecular pharmacology, or related discipline.
• Experience developing scalable high‑throughput cellular assays and adapting them for wide‑scale screening.
• Strong expertise in tissue culture, including maintenance of cancer cell lines, transient transfection, generation of stable and knockout/knock‑in lines, and molecular cloning.
• Excellent communication, presentation and interpersonal skills.
• Ability to work independently and collaboratively in multidisciplinary research teams.

Responsibilities

• Identify ubiquitin E3 ligases recruited to cancer targets and validate interactions in vitro and in cells.
• Develop and apply high‑throughput screening to find small molecules that act as molecular glues.
• Collaborate within the ACBI‑glue team in multidisciplinary drug discovery setting.
• Contribute to translational cancer therapeutics research.

Skills

High-throughput screening

Tissue culture

Molecular cloning

Collaboration

Independent work

Education

PhD in cell biology

Tools

TurboID proximity labelling

IP‑MS

Job description

The University of Dundee's CeTPD invites applications for a Postdoctoral Research Assistant to join the ACBI-glue team, focusing on developing molecular glue degraders for cancer targets.

You'll identify ubiquitin E3 ligases, validate interactions in cellular and in vitro systems, and apply high-throughput screening to discover small molecules that act as molecular glues, contributing to translational cancer therapeutics.